The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania
Authors:
- Heinz GrunzeHGHeinz Grunze
- Eduard VietaEduard Vieta
- Guy M GoodwinGGGuy M Goodwin
- Charles BowdenCBCharles Bowden
- Rasmus W LichtRLRasmus W Licht
- Hans-Jurgen MollerHMHans-Jurgen Moller
- Siegfried KasperSKSiegfried Kasper
- 1 January 2009
- journal article
- practice guideline
- Published by Taylor & Francis in The World Journal of Biological Psychiatry
- Vol. 10 (2) , 85-116
Abstract
These updated guidelines are based on a first edition that was published in 2003, and have been edited and updated with the available scientific evidence until end of 2008. Their purpose is to supply a systematic overview of all scientific evidence pertaining to the treatment of acute mania in adults. The data used for these guidelines have been extracted from a MEDLINE and EMBASE search, from the clinical trial database clinicaltrials.gov, from recent proceedings of key conferences, and from various national and international treatment guidelines. Their scientific rigor was categorised into six levels of evidence (A-F). As these guidelines are intended for clinical use, the scientific evidence was finally asigned different grades of recommendation to ensure practicability.Keywords
This publication has 217 references indexed in Scilit:
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac DeathNew England Journal of Medicine, 2009
- ECNP consensus meeting. Bipolar depression. Nice, March 2007European Neuropsychopharmacology, 2008
- Olanzapine versus lithium in the acute treatment of bipolar mania: A double-blind, randomized, controlled trialJournal of Affective Disorders, 2008
- Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2007
- Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004Journal of Affective Disorders, 2007
- Tardive dyskinesia: Analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin AmericaSchizophrenia Research, 2006
- Carbamazepine, Other Anticonvulsants and Augmenting Agents2005
- Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidolEuropean Neuropsychopharmacology, 2005
- Tiagabine in treatment refractory bipolar disorder: a clinical case seriesBipolar Disorders, 2002
- Lack of antimanic efficacy of the GABA transporter 1 inhibitor tiagabineEuropean Neuropsychopharmacology, 1998